Follow Us:
Amantadine Exporter From India

Amantadine

Amantadine is a medication used primarily to manage symptoms of Parkinson’s disease and certain drug-induced movement disorders. It works through mechanisms that include modulation of dopamine activity and antagonism of N-methyl-D-aspartate (NMDA) receptors, helping improve motor symptoms such as rigidity and reduced movement in selected patients. Depending on the formulation and country-specific approval, amantadine may also be used for other indications, including multiple sclerosis-related walking impairment. Historically, it was used against influenza A, but it is no longer recommended for routine influenza treatment because of widespread viral resistance. Common adverse effects include dizziness, insomnia, nausea, and dry mouth; more serious effects may include confusion, hallucinations, and low blood pressure. Dosage adjustment is often necessary in patients with impaired kidney function, and treatment should not be stopped abruptly without medical advice.

  • Dosage Form:
  • Dosage Strength:
  • Manufacturer:
  • CAS No.:
  • Status:

Applications of Amantadine

Amantadine was historically used as a respiratory medicine for the symptomatic management of certain respiratory conditions. Its former uses included:

is okay

Contraindication of Amantadine

Availability of Amantadine

Delivery of Amantadine

Frequently Asked Questions

The most frequently asked questions focus on import, export, documentations, and regulation for Amantadine.

The is a pharmaceutical active pharmaceutical ingredient (API) used in manufacturing of Amantadine.

: Provides active pharmaceutical ingredients (APIs), customized production, and OEM/ODM services with research and technical cooperation across Europe, the USA, and India via Primeera Healthcare.

  • Therapeutic Goods Administration (TGA):
  • US Food and Drug Administration (USFDA):
  • European Medicines Agency (EMA):
  • African Medicines Agency (AMA):
  • National Medical Products Administration (NMPA):
  • Central Drugs Standard Control Organization (CDSCO):

Primeera Healthcare Private Limited can provide import coordination and pharmaceutical documentation assistance for Amantadine, subject to confirmation of its current regulatory status and eligibility for import into India.

Documentation Required for Amantadine Import

The import of medicines into India is regulated by the Central Drugs Standard Control Organisation (CDSCO) under the Drugs and Cosmetics Act, 1940, and the Drugs and Cosmetics Rules, 1945. The regulatory requirements depend on whether the product is an active pharmaceutical ingredient (API), a finished formulation, or an unapproved medicine intended for an individual patient's treatment.

Import Regulations and dcoumentation for Amantadine

  • Import Documentation Assistance:
    Support with organising commercial invoices, packing lists, manufacturer details, product specifications, certificates of analysis, and other relevant documents required for regulatory review and customs processing.

  • Regulatory Coordination:
    Assistance with identifying applicable CDSCO requirements, import authorisations, and documentation procedures, subject to the product's regulatory status and the proposed import route.
  • Shipping and Customs Coordination:
    Coordination with relevant logistics providers and customs professionals to organise shipment documentation and facilitate clearance where legally permitted.
  • Compliance Verification:
    Preliminary review of available product and shipment documentation to identify potential regulatory gaps before procurement or dispatch. Import arrangements will proceed only after the applicable permissions and restrictions have been verified.

Customs Clearance and Compliance Handling of Amantadine Import

Primeera Healthcare Private Limited can provide import coordination and pharmaceutical documentation assistance for Amantadine, subject to confirmation of its current regulatory status and eligibility for import into India.

Export Regulations and dcoumentation for Amantadine

The export of Amantadine from India is subject to applicable requirements under the Drugs and Cosmetics Act, 1940, the Drugs and Cosmetics Rules, 1945, and relevant export, customs, and destination-country regulations. Documentation requirements depend on whether the product is an active pharmaceutical ingredient (API), a finished pharmaceutical formulation, or a medicine intended for a specific market. Export eligibility and destination-country requirements must be verified before shipment.

Documentation Required for Amantadine Emport

  • Export Documentation Assistance:
    Assistance with organising commercial invoices, packing lists, manufacturer details, Amantadine specifications, certificates of analysis, and other supporting documents required for Amantadine export and customs processing.
  • Regulatory Coordination:
    Support in identifying applicable country specific Amantadine export requirements, relevant manufacturing and export authorisations, and destination-country registration or import approval requirements, subject to the Amantadine regulatory status.
  • Shipping and Customs Coordination:
    Coordination with logistics providers, freight forwarders, and customs professionals to organise shipping documentation, export declarations, and customs clearance procedures where legally permitted.
  • Compliance Verification:
    Preliminary review of available Amantadine documentation, labelling, Amantadine manufacturing information, and destination-market requirements to identify potential regulatory gaps before dispatch. Export arrangements will proceed only after the applicable restrictions and authorisations have been verified.

Customs Clearance and Compliance Handling of Amantadine Export

Primeera Healthcare Private Limited can provide pharmaceutical export documentation assistance, regulatory coordination, and shipping support for Amantadine, subject to confirmation of its export eligibility under applicable Indian regulations and the import requirements of the destination country.

Product Export Support

If you have any questions or need any help, contact our Support Team. We will get in touch with you within 24 hours from Monday to Friday between 9:00 and 10:00 CET.

Email Us

info@primeerahealthcare.com

Call Us

+(123) 456 789 00

Follow Us

Primeera Healthcare

Disclaimer

All Trademarks and Brands that appear on the website belong to their respective owners. Primeera Healthcare does not lay any claim on them; we only provide information.